Mechanism of Action
Full agonist at the androgen receptor with high binding affinity. More potent than most other SARMs at the receptor level. Animal studies investigating it as a male contraceptive found it suppressed sperm production to zero at tested doses — the suppression was reversible but took months to recover. This level of HPTA suppression is comparable to traditional injectable anabolics.
Ester Profile
Non-steroidal oral SARM. Half-life of approximately 12 hours allows once or twice daily dosing. No ester.
How It's Used in Fitness
S23 is used in performance settings for its pronounced muscle hardening and fat loss effects, particularly in cutting and contest prep phases. Users describe physique effects similar to Winstrol or Masteron in terms of hardness and dryness. It is considered one of the more potent SARMs for body composition effects rather than mass building. Its use is less common than RAD-140 or LGD-4033 due to the severity of suppression and the complete absence of human safety data.
Stacking Context
S23 appears in cutting stacks alongside Testosterone Propionate as a base and with Cardarine for endurance, though Cardarine's cancer risk makes that combination inadvisable. It is sometimes combined with MK-677 to offset the suppression-related recovery impairment. Its use is typically standalone or with minimal additions because the suppression it produces already requires significant PCT planning.
Medical Use
- Investigated as male contraceptive in animal models — not in humans
- No approved human use
- No completed human clinical trials
Side Effects
- Severe testosterone suppression — sperm production reduced to zero in animal studies
- Prolonged fertility recovery potentially taking months
- Aggressive PCT required
- Androgenic effects — hair loss and acne
- Unknown long-term safety profile
- Mood changes — aggression and irritability reported
- Liver enzyme elevation in case reports
What Actually Goes Wrong
The suppression data from animal studies is alarming — sperm production dropped to zero at tested doses. While these were animal studies and translation to humans is not direct, the pattern suggests this is among the most suppressive SARMs available. Recovery of fertility and testosterone production after use may take significantly longer than with milder SARMs. No human safety data means the full risk profile is unknown. The potency that makes it interesting from a physique standpoint is inseparable from the suppression and safety unknowns.
Detection Window
WADA bans all SARMs. Specific S23 detection methodology evolving.
S23 sits in an unusual position where the physique effects are real and documented in animal and anecdotal human data, and the safety profile is more concerning than most SARMs precisely because of the contraceptive-level suppression observed in animal studies. If fertility is any concern whatsoever — now or in the future — S23 is not an appropriate compound to experiment with given the depth of suppression documented.